Literature DB >> 1656894

Outcome of confirmed symptomatic congenital cytomegalovirus infection.

M E Ramsay1, E Miller, C S Peckham.   

Abstract

Sixty five neonates with confirmed symptomatic congenital cytomegalovirus infection were followed up prospectively until they were 3 to 4 year of age. Twenty nine children (45%) had neurological impairment of whom 22 had gross motor or psychomotor abnormalities; in the remaining seven sensorineural deafness was the main abnormality. Infants who had had neurological signs during the neonatal period had a worse prognosis than those who had not, with 16/22 (73%) and 13/43 (30%) having neurological deficit at follow up, respectively. Our results indicate that the prognosis for infants with symptomatic congenital cytomegalovirus infection is better than previously reported.

Entities:  

Mesh:

Year:  1991        PMID: 1656894      PMCID: PMC1793063          DOI: 10.1136/adc.66.9.1068

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  12 in total

1.  Virologic and clinical observations on cytomegalic inclusion disease.

Authors:  T H WELLER; J B HANSHAW
Journal:  N Engl J Med       Date:  1962-06-14       Impact factor: 91.245

2.  Cytomegalic inclusion disease; an analysis of the clinical features based on the literature and six additional cases.

Authors:  D N MEDEARIS
Journal:  Pediatrics       Date:  1957-03       Impact factor: 7.124

3.  Early acquisition of cytomegalovirus infection.

Authors:  C S Peckham; C Johnson; A Ades; K Pearl; K S Chin
Journal:  Arch Dis Child       Date:  1987-08       Impact factor: 3.791

4.  Early clinical manifestations and intellectual outcome in children with symptomatic congenital cytomegalovirus infection.

Authors:  T J Conboy; R F Pass; S Stagno; C A Alford; G J Myers; W J Britt; F P McCollister; M N Summers; C E McFarland; T J Boll
Journal:  J Pediatr       Date:  1987-09       Impact factor: 4.406

5.  Inapparent congenital cytomegalovirus infection. A follow-up study.

Authors:  M L Kumar; G A Nankervis; E Gold
Journal:  N Engl J Med       Date:  1973-06-28       Impact factor: 91.245

6.  Long-term follow-up of cytomegalic inclusion disease of infancy.

Authors:  W Berenberg; G Nankervis
Journal:  Pediatrics       Date:  1970-09       Impact factor: 7.124

7.  Congenital cytomegalic inclusion disease. A longitudinal study of 20 patients.

Authors:  G H McCracken; H M Shinefield; K Cobb; A R Rausen; R Dische; H F Eichenwald
Journal:  Am J Dis Child       Date:  1969-05

8.  A growth chart for premature and other infants.

Authors:  D Gairdner; J Pearson
Journal:  Arch Dis Child       Date:  1971-12       Impact factor: 3.791

9.  Congenital cytomegalovirus infection.

Authors:  P M Preece; K N Pearl; C S Peckham
Journal:  Arch Dis Child       Date:  1984-12       Impact factor: 3.791

10.  Outcome of symptomatic congenital cytomegalovirus infection: results of long-term longitudinal follow-up.

Authors:  R F Pass; S Stagno; G J Myers; C A Alford
Journal:  Pediatrics       Date:  1980-11       Impact factor: 7.124

View more
  13 in total

1.  Hematological manifestations of congenital cytomegalovirus infection.

Authors:  H K Pemde; S K Kabra; R Agarwal; Y Jain; V Seth
Journal:  Indian J Pediatr       Date:  1995 Jul-Aug       Impact factor: 1.967

2.  Experimental confirmation of global murine cytomegalovirus open reading frames by transcriptional detection and partial characterization of newly described gene products.

Authors:  Qiyi Tang; Eain A Murphy; Gerd G Maul
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

3.  Clinical findings and adverse outcome in neonates with symptomatic congenital cytomegalovirus (SCCMV) infection.

Authors:  Ranjit I Kylat; Edmond N Kelly; Elizabeth Lee Ford-Jones
Journal:  Eur J Pediatr       Date:  2006-07-12       Impact factor: 3.183

4.  Beta2-microglobulin concentrations in cerebrospinal fluid correlate with neuroimaging findings in newborns with symptomatic congenital cytomegalovirus infection.

Authors:  Ana Alarcon; Alfredo Garcia-Alix; Fernando Cabañas; Angel Hernanz; Dora Pascual-Salcedo; Ana Martin-Ancel; Marta Cabrera; Alfredo Tagarro; Jose Quero
Journal:  Eur J Pediatr       Date:  2006-05-12       Impact factor: 3.183

5.  Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain.

Authors:  Adam L Feire; Heidi Koss; Teresa Compton
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-19       Impact factor: 11.205

Review 6.  Immediate-Early (IE) gene regulation of cytomegalovirus: IE1- and pp71-mediated viral strategies against cellular defenses.

Authors:  Lilith Torres; Qiyi Tang
Journal:  Virol Sin       Date:  2014-11-25       Impact factor: 4.327

7.  The glycoprotein B disintegrin-like domain binds beta 1 integrin to mediate cytomegalovirus entry.

Authors:  Adam L Feire; René M Roy; Kate Manley; Teresa Compton
Journal:  J Virol       Date:  2010-07-21       Impact factor: 5.103

8.  Human cytomegalovirus elicits a coordinated cellular antiviral response via envelope glycoprotein B.

Authors:  Karl W Boehme; Jasbir Singh; Stuart T Perry; Teresa Compton
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

Review 9.  Economic assessments of the burden of congenital cytomegalovirus infection and the cost-effectiveness of prevention strategies.

Authors:  Scott D Grosse; Sheila C Dollard; Ismael R Ortega-Sanchez
Journal:  Semin Perinatol       Date:  2021-01-23       Impact factor: 3.300

10.  The Zinc Finger Antiviral Protein ZAP Restricts Human Cytomegalovirus and Selectively Binds and Destabilizes Viral UL4/UL5 Transcripts.

Authors:  Ana Cristina Gonzalez-Perez; Markus Stempel; Emanuel Wyler; Christian Urban; Antonio Piras; Thomas Hennig; Sabina Ganskih; Yuanjie Wei; Albert Heim; Markus Landthaler; Andreas Pichlmair; Lars Dölken; Mathias Munschauer; Florian Erhard; Melanie M Brinkmann
Journal:  mBio       Date:  2021-05-04       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.